T cell costimulation through the immunological synapse
通过免疫突触进行 T 细胞共刺激
基本信息
- 批准号:7333667
- 负责人:
- 金额:$ 15.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdhesionsAgeAgingAging-Related ProcessAntigensAttenuatedCD28 geneCD4 Positive T LymphocytesCalciumCell AgingChromosome PairingDefectDevelopmentElementsEnhancersEventExclusionGenetic TranscriptionGoalsImmune responseIndividualInterleukin-2KineticsLifeMediatingMessenger RNAMicroscopyMolecularMolecular AnalysisMusNumbersPTPRC genePeripheralPhosphoric Monoester HydrolasesProcessProteinsRecruitment ActivitySecretory ComponentSignal TransductionSignaling MoleculeSiteSynapsesT-Cell ActivationT-LymphocyteTalinTestingTransgenic OrganismsUp-Regulationage effectcell agecellular imagingimmunological synapsereceptorresponse
项目摘要
DESCRIPTION (provided by applicant): The immune response is dramatically attenuated during aging. There are a number of factors that contribute to this phenomenon, one of which is an intrinsic defect in CD4 T cell activation. T cell activation takes place in the context of the immunological synapse, where receptors, cytoskeletal elements, and signaling molecules are organized into discreet domains at the T cell: APC interaction site. In the mature synapse the central region, cSMAC, contains the TCR, CD28, signaling components (PKCtheta), and secretory components. The peripheral region, pSMAC, contains LFA-1 and associated proteins talin and RAPL. The phosphatase, CD45, is recruited to the site of T cell: APC interaction, but largely excluded from the synapse. Recent evidence indicates that TCR signaling takes place in microclusters that form at the outside of the synapse and the cSMAC is a site of downmodulation of TCR signaling. In contrast, we have found that CD28 costimulation occurs within the cSMAC region, through the recruitment of PKCtheta and upregulation of IL-2 transcription. In addition, we have found that LFA-1-dependent formation of the pSMAC is required for the exclusion of the CD45 and this correlates with an increase in proximal signaling through the TCR. Thus, T cell costimulation through CD28 and LFA-1 may be mediated through the organization of proteins within the immunological synapse. There is good evidence that CD28 and LFA-1 functions are diminished in T cells from aged individuals. Thus the central hypothesis of this application is that aging results in a specific defect in the ability to target CD28 and/or LFA-1, or their associated proteins, to the cSMAC or pSMAC respectively and this results in a decrease in proximal T cell signaling that will account in part for the intrinsic defect in T cell activation in CD4 T cells from aged individuals. We will test this central hypothesis in 2 Aims: (1) Determine whether CD28 signaling within and/or outside the immunological synapse is downmodulated in T cells from aged mice and (2) Determine whether LFA-1 adhesion and/or immunological synapse organization is disrupted in T cells from aged mice. We will use TCR transgenic, CD28-deficient and LFA-1-deficient mice and a combination of immunofluorescent microscopy, live cell imaging, and molecular analysis. We will determine whether aging effects T cell: APC adhesion the kinetics, efficiency, or magnitude of recruitment and organization of TCR, LFA-1, CD28, or associated proteins into the immunological synapse. We will determine whether there is a corresponding defect in LFA-1 and/or CD28-associated signaling events and whether there is an alteration in the functional consequences these costimulatory signals. Finally, if a defect is noted in any of these events we will address the specific molecular process that accounts for a loss in LFA-1 and/or CD28 function during aging. The immune response is dramatically attenuated during aging in part due to a defect in T cell signaling. The overall goal of this project is to determine the precise cellular and molecular events that account for this defect. We hope that understanding the mechanism behind this aging process will facilitate the development of specific immuno-enhancers that can counteract these events and promote effect immune responses in older individuals.
描述(由申请人提供):免疫应答在衰老过程中显著减弱。有许多因素导致这种现象,其中之一是CD 4 T细胞活化的内在缺陷。T细胞活化发生在免疫突触的背景下,其中受体、细胞骨架元件和信号传导分子在T细胞:APC相互作用位点被组织成离散的结构域。在成熟突触的中心区域,cSMAC,包含TCR,CD 28,信号传导成分(PKC θ),和分泌成分。外周区pSMAC含有LFA-1和相关蛋白talin和RAPL。磷酸酶CD 45被募集到T细胞与APC相互作用的位点,但大部分被排除在突触之外。最近的证据表明,TCR信号传导发生在突触外部形成的微簇中,并且cSMAC是TCR信号传导下调的位点。相反,我们发现CD 28共刺激发生在cSMAC区域内,通过募集PKC θ和上调IL-2转录。此外,我们已经发现,LFA-1依赖性pSMAC的形成是排除CD 45所必需的,并且这与通过TCR的近端信号传导的增加相关。因此,通过CD 28和LFA-1的T细胞共刺激可以通过免疫突触内的蛋白质的组织来介导。有很好的证据表明,CD 28和LFA-1功能在老年人的T细胞中减少。因此,本申请的中心假设是老化导致将CD 28和/或LFA-1或其相关蛋白分别靶向cSMAC或pSMAC的能力的特异性缺陷,并且这导致近端T细胞信号传导的减少,这将部分地解释来自老年个体的CD 4 T细胞中T细胞活化的内在缺陷。我们将在2个目标中检验这一中心假设:(1)确定免疫突触内和/或外的CD 28信号传导在来自老年小鼠的T细胞中是否被下调,以及(2)确定LFA-1粘附和/或免疫突触组织在来自老年小鼠的T细胞中是否被破坏。我们将使用TCR转基因、CD 28缺陷和LFA-1缺陷小鼠,并结合免疫荧光显微镜、活细胞成像和分子分析。我们将确定老化是否影响T细胞:APC粘附TCR,LFA-1,CD 28或相关蛋白进入免疫突触的募集和组织的动力学,效率或幅度。我们将确定LFA-1和/或CD 28相关信号事件是否存在相应的缺陷,以及这些共刺激信号的功能后果是否发生改变。最后,如果在任何这些事件中发现缺陷,我们将解决在老化过程中LFA-1和/或CD 28功能丧失的特定分子过程。免疫反应在衰老过程中显着减弱,部分原因是T细胞信号传导的缺陷。该项目的总体目标是确定导致这种缺陷的精确细胞和分子事件。我们希望了解这种衰老过程背后的机制将有助于开发特异性免疫增强剂,可以抵消这些事件并促进老年人的有效免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIM F Miller其他文献
JIM F Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIM F Miller', 18)}}的其他基金
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
- 批准号:
10241367 - 财政年份:2014
- 资助金额:
$ 15.79万 - 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
- 批准号:
10477319 - 财政年份:2014
- 资助金额:
$ 15.79万 - 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
- 批准号:
10689177 - 财政年份:2014
- 资助金额:
$ 15.79万 - 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
- 批准号:
10002193 - 财政年份:2014
- 资助金额:
$ 15.79万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.79万 - 项目类别:
Research Grant














{{item.name}}会员




